Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comprehensive immune ageing reveals TREM2/TIM3 myeloid cells drive brain immune evasion

  • Segura-Collar, Berta
  • Mondejar-Ruescas, Lucia
  • Alcivar-López, Denisse
  • Garranzo-Asensio, María
  • Mata-Martinez, Pablo
  • Garcia-Escudero, Ramón
  • Hernández-Laín, Aurelio
  • Sepúlveda, Juan M.
  • Nuñez, Ángel Pérez
  • Avila, Jesús
  • Sánchez-Gómez, Pilar
  • Gargini, Ricardo
Background: Ageing-dependent low-grade inflammation is a hallmark of central nervous system (CNS) diseases. Vascular and immune abnormalities are implicated in the progression of gliomas and occur in the early stages of Alzheimer's disease (AD); however, the mechanisms by which these alterations manifest in the brain parenchyma remain unclear. Methods: Using RNAseq, scRNAseq, bioinformatics tools and a cohort of patients with glioma and Alzheimer's disease for validation of results, we have established an analysis of blood–brain barrier (BBB) dysfunction and neuron loss. A mouse model for glioblastoma pathology was also used that reversed BBB disruption and neuron loss, with the incorporation of the IDH mutation. Finally, we established a characterization of the relevant immune populations with an IHC analysis and transcriptional profile. Findings: In this study, molecular analyses of the brain ecosystem revealed that blood–brain barrier dysfunction and neuronal synapse integrity exhibit significant threshold-dependent changes that correlate directly and inversely, respectively, with brain ageing (significant changes at 57 years) and the progression of AD and gliomas (survival of 1525 vs 4084 days for patients with High vs Low BBB dysfunction). Using human samples and mouse models, we identified immunoageing processes characterized by an imbalance between pro-inflammatory and anti-inflammatory signals. This dysregulation promotes the extravasation of monocyte-derived macrophages (85% increase of cells), particularly those with a suppressive phenotype, alongside an increase in inflammatory cytokine levels. Notably, our data show that vascular normalization in a glioma model can reverse neuronal loss and attenuate the aggressiveness of the tumours. Finally, tumour development can be prevented by reactivating the ageing immune system. Interpretation: We propose that the ageing brain represents a common, BBB dysfunction-associated process driving chronic inflammation. This inflammation is regulated by TREM2+/TIM3+ suppressive myeloid cells, which play a central role in disease progression. Our findings suggest that targeting these pathways could offer therapeutic strategies to mitigate CNS pathologies linked to ageing, characterized by toxic neuroinflammation and myeloid dysfunction. Funding: This study was funded by ISCIII and co-funded by the European Union., We thank all members of the Neuro-oncology Group and UNMO, Sara Hiller-Vallina, Blanca Comitre and Marina I. Garin for critical discussion of the manuscript and the Pathological Anatomy Service and IMAS12 Core Facilities and the Animal Facilities Service (ISCIII) for their excellent assistance. We also thank the Cancer Research & Innovation in Science (CRIS contra el Cancer) Organization for the financial support they provide to the laboratory to carry out our research. This study was funded by ISCIII and FEDER funds: (CP21/00116 and PI22/01171) (R.G.), (CD21/00080) (B.S-C), PI21CIII/00002 (P.S-G), PI21/01406 (J.M-S), PI21/01168 (A.P-N); by ABTA (ARC2300007) (P.S-G), and by FC-AECC (INVES192GARG) (RG).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human RAP2A homolog of the Drosophila asymmetric cell division regulator Rap2l targets the stemness of glioblastoma stem cells

  • Franco, Maribel
  • Gargini, Ricardo
  • Barberá, Víctor Manuel
  • Saceda, Miguel
  • Carmena, Ana
Asymmetric cell division (ACD) is a fundamental process to balance cell proliferation and differentiation during development and in the adult. Cancer stem cells (CSCs), a very small but highly malignant population within many human tumors, are able to provide differentiated progeny by ACD that contribute to the intratumoral heterogeneity, as well as to proliferate without control by symmetric, self-renewing divisions. Thus, ACD dysregulation in CSCs could trigger cancer progression. Here, we consistently find low expression levels of RAP2A, the human homolog of the Drosophila ACD regulator Rap2l, in glioblastoma (GBM) patient samples, and observe that scarce levels of RAP2A are associated with poor clinical prognosis in GBM. Additionally, we show that restitution of RAP2A in GBM neurosphere cultures increases the ACD of glioblastoma stem cells (GSCs), decreasing their proliferation and expression of stem cell markers. Our results support that ACD failures in GSCs increase their spread and ACD amendment could contribute to reduce the expansion of GBM., We thank the Bloomington Drosophila Stock Center at the University of Indiana and the Developmental Studies Hybridoma Bank at the University of Iowa for kindly providing fly strains and reagents. RG was funded by ‘P through the project Miguel Servet Contracts’ (CP21/00116), PI22/01171, and co-funded by the European Union. MS was supported by the Spanish grant from the Instituto de Salud Carlos III (ISCIII) PI22/00824. AC was financed by the Spanish grants from the Ministry of Science, Innovation and Universities (PGC2018-097093-B-100), the Ministry of Science and Innovation (PID2021-123196NB-100), the Generalitat Valenciana Prometeo/2021/052 grant, and the European Regional Development Fund (FEDER). The ‘Instituto de Neurociencias’ in Alicante is a ‘Severo Ochoa Center of Excellence in R&D’. Our group belongs to ‘Conexión Cáncer (CSIC)’., Peer reviewed